Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Ruxolitinib sulfate

😃Good
Catalog No. T61988Cas No. 1092939-16-6

Ruxolitinib sulfate (INCB018424 sulfate) is a potent, selective inhibitor of JAK1/2 with IC50 values of 3.3 nM/2.8 nM, demonstrating over 130-fold selectivity for JAK1/2 compared to JAK3.

Ruxolitinib sulfate

Ruxolitinib sulfate

😃Good
Catalog No. T61988Cas No. 1092939-16-6
Ruxolitinib sulfate (INCB018424 sulfate) is a potent, selective inhibitor of JAK1/2 with IC50 values of 3.3 nM/2.8 nM, demonstrating over 130-fold selectivity for JAK1/2 compared to JAK3.
Pack SizePriceAvailabilityQuantity
25 mg$1,5208-10 weeks
50 mg$1,9808-10 weeks
100 mg$2,5008-10 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Ruxolitinib sulfate (INCB018424 sulfate) is a potent, selective inhibitor of JAK1/2 with IC50 values of 3.3 nM/2.8 nM, demonstrating over 130-fold selectivity for JAK1/2 compared to JAK3.
In vitro
Ruxolitinib sulfate (INCB018424 sulfate) effectively and selectively hampers JAK2V617F-mediated signaling and cell growth, significantly boosts apoptosis in a dose-dependent manner, and achieves a twofold increase in cells with depolarized mitochondria at a concentration of 64 nM in Ba/F3 cells. It also exhibits exceptional efficacy in inhibiting erythroid colony formation, noted by an IC50 of 67 nM. Moreover, it suppresses the proliferation of erythroid progenitors from both healthy individuals and patients with polycythemia vera, as evidenced by IC50 values of 407 nM and 223 nM, respectively [1].
In vivo
Ruxolitinib (INCB018424 sulfate; 180 mg/kg, orally, twice daily) achieves over a 90% survival rate by day 22 and significantly reduces splenomegaly and inflammatory cytokine levels in a JAK2V617F-driven mouse model, effectively targeting and eradicating neoplastic cells without causing myelosuppression or immunosuppression [1]. In myelofibrosis patients within a double-blind trial, 41.9% reached the primary endpoint with Ruxolitinib treatment compared to 0.7% in the placebo group, demonstrating its efficacy in reducing spleen volume and improving symptoms [2]. Additionally, 28% of patients receiving Ruxolitinib (15 mg twice daily) experienced at least a 35% reduction in spleen volume by week 48, a stark contrast to none in the best available therapy group, with a 56% reduction in mean palpable spleen length versus a 4% increase with alternative treatments. Ruxolitinib also significantly improves overall quality of life and reduces myelofibrosis symptoms [3].
Chemical Properties
Molecular Weight404.45
FormulaC17H20N6O4S
Cas No.1092939-16-6
Storage & Solubility Information
StorageShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Ruxolitinib sulfate | purchase Ruxolitinib sulfate | Ruxolitinib sulfate cost | order Ruxolitinib sulfate | Ruxolitinib sulfate chemical structure | Ruxolitinib sulfate in vivo | Ruxolitinib sulfate in vitro | Ruxolitinib sulfate formula | Ruxolitinib sulfate molecular weight